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Abstract
The search for genetic causes of common complex diseases has been revolutionized
by the ability to genotype exceptionally large numbers of single nucleotide polymor-
phisms (SNPs) in hundreds of individuals at an affordable cost. Statistical analysis
of the data generated in hundreds of such genome-wide association studies has been
able to identify genetic risk variants with differing degrees of success. Overall, these
genetic risk variants account only for a fraction of the observed genetic heritability.
Reasons suggested for this shortcoming range from the identification of statistical
problems with conventional analysis tools to the failure to model the complexity of
the human organism properly. One proposition to uncover a portion of the ’missing
heritability’ is the analysis of biologically meaningful SNP sets. Methods based on
SNP sets are typically powerful and aid the interpretation of results through the
incorporation of biological knowledge.
A popular approach in the identification of associations between an investigated dis-
ease and SNP sets lies in kernel methods, in particular the logistic kernel machine test.
Such methods formulate the estimation problem in a reproducing kernel Hilbert space
of functions, which is uniquely defined by a positive semi-definite kernel. This has the
benefit of facilitating the construction and estimation of a wide variety of genetic effect
models. However, this immense flexibility can also prove problematic. The choice
of kernel most suitable for a particular problem is seldom obvious and the choice
made seriously affects the ability of the kernel method to discover genuine associations.
One of the main objectives of this thesis is the development of appropriate kernels
for the analysis of SNP sets, such as genes or pathways. Here, a pathway is defined
as a network of interacting genes responsible for achieving a specific cell function or
regulation. In this thesis, I introduce a kernel that corrects for bias incurred through
differently-sized pathways in terms of the number of SNPs or genes. This kernel also
reflects the basic architecture of a pathway. This concept is expanded by constructing
another kernel that integrates specific gene-gene regulations. Through simulation
studies and implementation of real data on rheumatoid arthritis and lung cancer,
I demonstrate both robustness as well as practical usefulness of the logistic kernel
machine test with the two kernels introduced above.
Another main objective of this thesis is to compare kernel methods with other
approaches in the analysis of pathways or genes. This includes comparing the
performance of various multi-marker methods for ranking genes according to their
strength of association with an investigated disease. In many genetic scenarios, it
is possible to show that the performance of kernel methods is superior. In addition,
this thesis includes a comparative study of chips currently used to genotype SNPs
in the human genome. The chips are assessed with regard to their coverage of the
genome, price, and efficiency.
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Zusammenfassung
Die Möglichkeit Millionen von Single Nucleotide Polymorphisms (SNPs) kostengünstig in hun-
derten Individuen zu genotypisieren hat die Suche nach den genetischen Ursachen komplexer
Krankheiten revolutioniert. Die Analyse der Daten solcher genomweiter Assoziationsstudien
konnte mit sehr unterschiedlichem Erfolg Risikovarianten identifizierten. Die so identifizierten
Risikovarianten konnten jedoch nur Bruchteile der geschätzten genetischen Erblichkeit erklären.
Erklärungen für den bislang eingeschränkten Erfolg reichen von statistischen Probleme der
konventionellen Analysemethoden zu Versäumnissen die Komplexität des menschlichen Organ-
ismus adäquat zu modellieren. Ein Vorschlag um Teile der unentdeckten Erblichkeit zu finden
ist die Analyse von biologisch sinnvollen SNP-Gruppen. Methoden, die auf SNP-Gruppen
basieren, sind typischerweise mächtig und helfen bei der Interpretation von Ergebnissen durch
den Einbezug biologischen Wissens.
Beliebte Verfahren zur Bestimmung von Assoziationen zwischen der untersuchten Krankheit
und SNP-Gruppen sind Kernmethoden, insbesondere der Kernel Logistic Machine Test. In
solchen Verfahren wird das Schätzproblem in einem Reproducing-Kernel-Hilbert-Raum,
welcher durch die Wahl eines positiv semidefiniten Kernes vollständig und eindeutig bestimmt
ist, formuliert. Dies hat den Vorteil ,dass es die Konstruktion und Schätzung einer Vielzahl an
genetischen Modellen erlaubt; allerdings kann diese immense Flexibilität auch problematisch
sein. Die Wahl eines Kernes ist nur selten offensichtlich, aber wirkt sich entscheidend auf die
Fähigkeit der Methode wahre genetische Assoziationen zu entdecken aus.
Diese Arbeit hat das Ziel angemessene Kerne für die Analyse von SNP-Gruppen, wie
zum Beispiel Gene oder biologische Reaktionspfade, zu konstruieren. Ein Reaktionspfad ist
hierbei definiert als ein Netzwerk interagierender Gene, die zusammen die spezifische Funktion
oder Regulierung einer Zelle erreichen. Diese Dissertation führt einen Kern mit Korrektur
für die verschiedenen Reaktionspfadsgrössen, gemessen an der Anzahl der SNPs oder Gene,
ein. Dieser Kern reflektiert gleichzeitig die Grundarchitektur eines Reaktionspfades. Mit
der Konstruktion eines weiteren Kernes, der spezifische Gen-Gen Interaktionen integriert,
wird dieses Konzept weiterentwickelt. Die Robustheit und die praktische Relevanz dieser
Entwicklung wird mit Hilfe einer Simulationsstudie sowie der Anwendung der Methode auf
realen Datensätze zu Rheumatoid Arthritis und Lungenkrebs demonstriert.
Ein weiteres Ziel dieser Arbeit ist der Vergleich von Kernmethoden zu anderen gängigen
Verfahren für die Analyse von Genen oder Reaktionspfaden. Dies beinhaltet den Vergleich
verschiedener Verfahren für die Analyse mehrerer SNPs. Die Verfahren werden anhand
ihres Vermögens die Stärke von Gen-Krankheitsassoziationen korrekt Ränge zu zuordnen
verglichen. Für viele genetische Szenarien, sind Kernmethoden überlegen. Darüberhinaus
enthält diese Dissertation eine komparative Studie von Chips für die Genotypisierung von
SNPs im menschlichen Genom. Diese Chips wurden mit Augenmerk auf die Abdeckung des
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1.1 The Current State of Genome-Wide Association Studies
Since decoding the human genome sequence in 2003, genetic epidemiologists inter-
ested in the genetic causes of common diseases shifted their focus from mutations
clustering in families to genetic variation commonly occurring in the entire population.
Family-based approaches, such as linkage analysis, had mostly failed to establish
causal genetic factors for diseases not characterized by the Mendelian properties of
monogenic diseases. The failure of family-based approaches with regards to common
diseases can mainly be attributed to the fact that such diseases evidently do not
solely result from variations in one genetic region. Indeed, most diseases are believed
"to have complex architectures [...], for which the phenotype is determined by the sum
total of, and/or interactions between, multiple genetic and environmental factors"
(Hirschhorn and Daly, 2005). In case of common diseases, the term "common disease
common variant" (CDCV) is used to refer to this hypothesis and several studies have
provided evidence for its plausibility (Koeleman, Al-Ali, van der Laan, and Assel-
bergs, 2013). Under this hypothesis, family-based approaches would have required
impractically large sample sizes in order to detect genetic risk factors (Risch and
Merikangas, 1996; Risch, 2000). Instead, with advances in genotyping technologies and
the cataloging of millions of single nucleotide polymorphisms (SNPs) genome-wide
case-control studies became affordable and increasingly popular for the detection of
genetic risk variants for common complex diseases.
A genome-wide case-control study, which is one type of genome-wide association
study (GWAS), surveys most of the genome for SNPs with a different frequency of
genotypes between cases and controls. SNPs are the genetic marker of choice since
they are the most abundant type of genetic variation, feasible for high throughput
and at the same time provide comprehensive coverage of the genome. By definition,
SNP refers to any bi-allelic genetic variation found in more than 1% of a population.
The dbSNP database (ncbi.nlm.nih.gov/SNP), which collects genetic markers, in-
cluded information on more than 18 million validated SNPs in July 2013. Using this
catalogue and information on linkage disequilibrium (LD) structures, researchers
are able to select SNPs that most effectively and efficiently capture the majority of
the variation in the genome. In particular, haplotype blocks can be represented by
just very few SNPs since such genetic regions are rarely broken by recombination.
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Thus, SNPs located in such regions can be called with the help of simple correlation
measures. Today, available genome-wide genotype arrays range from 500,000 SNPs to
4,3 million SNPs and accordingly offer different coverage of the genome (Ha, Freytag,
and Bickeböller, 2014).
The knowledge gain due to GWASs has received mixed evaluations (Visscher and
Montgomery, 2009). Certainly, before the beginning of the initial wave of large-scale
GWAS such studies were believed to greatly advance our understanding of the genetic
basis underlying common diseases (Hirschhorn and Daly, 2005; Cardon and Bell,
2001). Indeed, for traits, like inflammatory bowel disease and breast cancer, it was
possible to replicate and biologically verify a tremendous amount of genetic risk
factors. In 2011, there were over 2,000 genetic markers that had been shown to be
robustly associated with one or more complex traits (Visscher, Brown, McCarthy,
and Yang, 2012). In some cases, the discoveries resulting from the analysis of GWASs
have even been translated into medical treatments. For example, psoriasis medication,
which neutralizes IL-17 involved in the regulation of inflammatory circuits, was
developed after an association between IL-17 and psoriasis had been determined
using GWASs (Krueger, Fretzin, Suárez-Fariñas, Haslett, Phipps, Cameron, McColm,
Katcherian, Cueto, White, Banerjee, and Hoffman, 2012). Nevertheless, the total
amount of heritability explained by the newly discovered genetic risk factors has
remained below the often unreasonably high expectations of some scientists. In
general, established genetic risk factors "fail to explain the vast majority of genetic
heritability for any human disease, either individually or collectively" (Manolio,
Collins, Cox, Goldstein, Hindorff, Hunter, McCarthy, Ramos, Cardon, Chakravarti,
Cho, Guttmacher, Kong, Kruglyak, Mardis, Rotimi, Slatkin, Valle, Whittemore,
Boehnke, Clark, Eichler, Gibson, Haines, Mackay, McCarroll, and Visscher, 2009).
The bulk of identified markers was of no immediate clinical utility nor was their
biological relevance for the investigated disease apparent.
The reasons for the shortcomings of GWASs and "the mystery of the missing
heritability" (Manolio, Collins, Cox, Goldstein, Hindorff, Hunter, McCarthy, Ramos,
Cardon, Chakravarti, Cho, Guttmacher, Kong, Kruglyak, Mardis, Rotimi, Slatkin,
Valle, Whittemore, Boehnke, Clark, Eichler, Gibson, Haines, Mackay, McCarroll,
and Visscher, 2009) have been hotly debated in the genetic research community.
Several convincing opinions concerning the source of the missing heritability and
accompanying search strategies have been put forward (Eichler, Flint, Gibson, Kong,
Leal, Moore, and Nadeau, 2010). Genome-wide genotype arrays do only contain some
rare variants (Manolio, Collins, Cox, Goldstein, Hindorff, Hunter, McCarthy, Ramos,
Cardon, Chakravarti, Cho, Guttmacher, Kong, Kruglyak, Mardis, Rotimi, Slatkin,
Valle, Whittemore, Boehnke, Clark, Eichler, Gibson, Haines, Mackay, McCarroll, and
Visscher, 2009) and often fail to adequately cover copy number variations (Mefford
and Eichler, 2009). Both are collectively frequent variations in the genome and have
so far been inadequately examined for their role in the development and progression of
common diseases. However, new sequencing technology enabling the analysis of exons
or even the whole genome should change this in the coming years. It has also been
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suggested that the failure of analyses to consider a transgenerational genetic effects,
such as impriniting, is a possible source of the missing heritability (Kong et al., 2009).
In this case, phased genotype data or sequence data might lead to the discovery of
a substantial proportion of the missing heritability. Interaction with environmental
factors has further been named as a possible explanation and their careful inclusion
in analyses of GWASs has been called for (Eichler, Flint, Gibson, Kong, Leal, Moore,
and Nadeau, 2010). Yet another explanation might lie in the architecture of genetic
effects, in particular highly complex interconnected networks of genes responsible for
the manifestation of diseases (Zuk, Hechter, Sunyaev, and Lander, 2012). Solving
the mystery of the missing heritability would accordingly require the application of
novel statistical methods that incorporate a systems biological perspective. Finally,
missing heritability could be the consequence of low statistical power that obstructs
the success of most GWASs (Gibson, 2010). Conventional individual testing for
association with each SNP leads to immense problems with multiple testing. Already
in case of small genome-wide arrays, the application of appropriate corrections for
multiple testing leads to high false-negative rates. Here, considering the joint effect
of multiple genetic markers on the risk of being affected by the disease could help to
increase statistical power.
The analysis of biologically meaningful sets of SNPs has been proposed as a new
methodological approach to identify further genetic risk factors and therefore ex-
plain a part of the missing heritability. By simultaneously considering biologically
related SNPs this approach provides a substantial boost of power. On the one hand,
this is due to the potential to jointly detect moderate to low effects of multiple
SNPs (Fridley and Patch, 2011) and the subsequent reduction of the multiple testing
burden. On the other hand, simultaneous analysis allows researchers to consider
complex genetic architectures. Moreover, the reintroduction of biological concepts
through the use of biologically meaningful sets of SNPs may aid researchers in the
interpretation and utilization of their results (Wang, Li, and Hakonarson, 2010).
One of the most frequently investigated SNP sets is the gene. Genes constitute
a particularly attractive genetic unit, since mutations in such regions are known
to directly impact the functionality of the human organism. Furthermore, genes
located on the human genome have been well annotated in projects such as ENCODE
(Rosenbloom, Dreszer, Pheasant, Barber, Meyer, Pohl, Raney, Wang, Hinrichs, Zweig,
Fujita, Learned, Rhead, Smith, Kuhn, Karolchik, Haussler, and Kent, 2009) and their
locations as well as other properties can be accessed via several online databases
(Wheeler, Barrett, Benson, Bryant, Canese, Chetvernin, Church, DiCuccio, Edgar,
Federhen, Geer, Kapustin, Khovayko, Landsman, Lipman, Madden, Maglott, Ostell,
Miller, Pruitt, Schuler, Sequeira, Sherry, Sirotkin, Souvorov, Starchenko, Tatusov,
Tatusova, Wagner, and Yaschenko, 2007). Another unit frequently of interest is the
pathway. The pathway represents a collection of interacting genes that coordinate to
achieve a specific cell function or cell response as part of a biological process, such
as metabolic processes (Cantor, Lange, and Sinsheimer, 2010). Genes belonging to
the same pathway form complex networks that regulate the particular response or
function. If genetic variations disrupt a sufficient fraction of the pathway, its ability
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to regulate might be severely damaged, which can in turn lead to the manifestation
of a disease. Similarly to genes, pathways have been collected in numerous online
databases (Viswanathan, Seto, Patil, Nudelman, and Sealfon, 2008), which often
provide detail about their functionality within the human organism. However, these
data bases often disagree, are ambiguous about the exact structures of the networks
and miss information on considerable parts of the human organism.
There exist a broad range of multiple marker methods for the analysis of sets of
SNPs and several more specialized approaches targeted towards detecting pathway-
disease associations. One of the earliest pathway analysis methods was gene-set
enrichment analysis by Wang, Li, and Bucan (2007). In this approach, genes in the
pathway are assigned their strongest empirical p-value obtained from single marker
tests with all SNPs located in the gene. Using a weighted Kolmogorov-Smirnov-like
running sum statistics, each pathway is assessed in order to determine whether genes
with small p-values are overrepresented in the investigated pathway. There have been
several extensions of this method; most notably Yu, Li, Bergen, Pfeiffer, Rosenberg,
Caporaso, Kraft, and Chatterjee (2009) introduced the adaptive rank truncated prod-
uct statistic in order to evaluate the association of a gene. Another pathway analysis
approach, the hierarchical Bayes prioritization, relies on the Bayesian framework
to prioritize markers using prior biological information such as gene and pathway
membership (Lewinger, Conti, Baurley, Triche, and Thomas, 2007). Both gene-set en-
richment analysis and hierarchical Bayes prioritization depend upon individual testing
with each SNP. Thus, they are characterized by some of the disadvantages burdening
single marker testing. Namely, the effect of a SNP is estimated independently of all
others. Kernel methods do not share this dependence on single marker testing. In-
stead, their flexible framework, which consists of a covariance structure reflecting the
genetic similarity between all pairs of individuals, enables modeling of highly complex
SNP-SNP interactions. Furthermore, kernel methods applied to GWASs have proven
extremely powerful (Pan, 2009; Wu, Kraft, Epstein, Taylor, Chanock, Hunter, and
Lin, 2010) and their superior performance compared to other pathway-based methods,
in particular gene-set enrichment analysis and hierarchical Bayes prioritization, have
been empirically established (Freytag, Bickeböller, Amos, Kneib, and Schlather, 2012).
1.2 Kernel Methods for the Analysis of Genome-Wide Association
Studies
Kernel methods, which include nonparametric regression, smoothing splines and
support vector machines, are particularly well suited to cope with the challenges
connected to the analysis of GWAS: high dimensionality, non-linearity of genetic
effects and heterogeneity of data types. Kernel methods transform the data into a set
of points in a high dimensional space. The kernel, the name-sake of these methods,
acts thereby as a function that enables operations in this new space without the need
to explicitly compute the coordinates of the data in this particular space. This is
4
1 Introduction
often easier than the explicit computation and thus can prove highly advantageous.
This feature also ensures that high-dimensional data can usually be modeled without
encountering computational problems or extreme power losses. In this new space,
the data can be modeled linearly using a variety of statistical models (Hofmann,
Schölkopf, and Smola, 2008). These modeled relationships need not necessarily be
linear in the original space. Even though the kernel is restricted to be positive
semi-definite or positive definite, there is a wide spectrum of choice for the kernel.
This flexibility can also be exploited to incorporate different types of data. However,
this immense flexibility can also be problematic as it is difficult to know which kernel
to apply for a specific research problem.
The kernel machine test, a member of the class of kernel methods, was originally
developed for gene expression data (Liu, Ghosh, and Lin, 2008), it has been extended
to enable testing associations between multiple genetic variants, i.e. genotypes, and
a phenotype of interest (Wu, Kraft, Epstein, Taylor, Chanock, Hunter, and Lin,
2010). To this end, the kernel converts the genetic information into pairwise similarity
between individuals. At this stage, essentially a simple linear test for correlation
between the pairwise similarity of phenotypes and pairwise similarity of genotypes
suffices (Wu, Maity, Lee, Simmons, Harmon, Lin, Engel, Molldrem, and Armistead,
2013). This methodology has several advantages compared to ordinary tests that rely
on multiple regression. Firstly, kernel machine testing has the ability to detect the
joint effect of several moderately associated genetic variants even in the absence of
large main effects (Wu, Kraft, Epstein, Taylor, Chanock, Hunter, and Lin, 2010).
Secondly, directionality information regarding the effect of the genetic variants is not
required. Finally, its versatile kernel framework enables the modeling of complex
non-linear relationships as long as these can be formulated using positive definite or
semi-positive definite functions (Schölkopf and Smola, 2002).
The kernel machine test can be shown to be equivalent to a score test applied to an
appropriately specified generalized linear mixed model (GLMM). In brief, the influence
of the genetic variants is described by random effects with a correlation matrix gener-
ated by the kernel (Schaid, 2010a). Other variables that are informative in the context
of the investigated phenotype, such as age and sex, can be entered as fixed effects into
the model. The score test is then used to test whether or not the common variance
of the random effects is zero. A non-zero variance would point to an influence of the
tested genetic variants on the phenotype. Hence, it is sometimes referred to as a vari-
ance component test. Indeed, there exist other variance component tests for multiple
genetic variants that can be shown to be closely related to kernel machine testing, like
the weighted sum of squared score test by Pan (Pan, 2009; Pan, Han, and Shen, 2010).
The performance of the kernel machine test crucially depends on the choice of the
kernel, because it subsumes the underlying model of genotype-phenotype relationship.
However, knowing the precise nature of the relationship specified in the kernel is not al-
ways possible or computationally feasible, since this requires the back-transformation
of the converted data to the original space. In case of the frequently applied linear
5
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kernel the underlying genetic model is known to be linear. Using this kernel, when the
underlying genetic model includes interactions between genotypes, called epistasis,
leads to reduced power (Wu, Kraft, Epstein, Taylor, Chanock, Hunter, and Lin, 2010).
Furthermore, Freytag, Bickeböller, Amos, Kneib, and Schlather (2012) demonstrated
that this kernel does not maintain type I error when applied in combination with the
Satterthwaite approximation (for an explanation of this approximation see Section
2.2).
Successful applications of the kernel machine test have included GWAS with a di-
verse range of traits and disorders (Freytag, Bickeböller, Amos, Kneib, and Schlather,
2012; Wu, Kraft, Epstein, Taylor, Chanock, Hunter, and Lin, 2010; Shui, Mucci,
Wilson, Kraft, Penney, Stampfer, and Giovannucci, 2012; Locke, Dooley, Tinker,
Cheong, Feingold, Allen, Freeman, Torfs, Cua, Epstein, Wu, Lin, Capone, Sherman,
and Bean, 2010). In the case of dichotomous traits, like disease status, the kernel
machine test is also called logistic kernel machine test due to its use of the logistic
link function (corresponding to logistic regression). Besides dichotomous and quan-
titative traits, the kernel machine test has also been extended to be applicable to
data types such as censored survival data (Lin, Cai, Wu, Zhou, Liu, Christiani, and
Lin, 2011), multivariate (Maity, Sullivan, and Tzeng, 2012) or family data (Malzahn,
Friedrichs, Rosenberger, and Bickeböller, 2013). Furthermore, Larson and Schaid
(2013) demonstrated that the kernel machine test is "a powerful approach toward
detecting gene-gene interactions even in the absence of marginal effects." Most impor-
tantly, the kernel machine test has emerged as one of the more frequently encountered
methods for the analysis of whole genome or exon sequence data (Wu, Lee, Cai,
Li, Boehnke, and Lin, 2011; Nuytemans, Bademci, Inchausti, Dressen, Kinnamon,
Mehta, Wang, Züchner, Beecham, Martin, et al., 2013; Neale, Kou, Liu, Maáyan,
Samocha, Sabo, Lin, Stevens, Wang, Makarov, Polak, Yoon, Maguire, Crawford,
Campbell, Geller, Valladares, Schafer, Liu, Zhao, Cai, Lihm, Dannenfelser, Jabado,
Peralta, Nagaswamy, Muzny, Reid, Newsham, Wu, Lewis, Han, Voight, Lim, Rossin,
Kirby, Flannick, Fromer, Shakir, Fennell, Garimella, Banks, Poplin, Gabriel, DePristo,
Wimbish, Boone, Levy, Betancur, Sunyaev, Boerwinkle, Buxbaum, Cook Jr, Devlin,
Gibbs, Roeder, Schellenberg, Sutcliffe, and Daly, 2012). This is because it is able to
handle rare variants effectively and efficiently with regards to computation time.
This PhD thesis is concerned with the performance and methodological advancement
of kernel methods for the analysis of genome-wide association data using genes or
pathways. In particular, the choice or developmemt of an appropriate kernel for
the analysis of genome-wide association data integrating pathway information. The
findings presented are not just of statistical and methodological interest, but have
implications for medicine as well as genetics.
Due to its cumulative nature, the thesis is organized in the following manner:
Chapter 2 provides a brief technical description of the basic principles behind kernel
methods and establishes the equivalence of the logistic kernel machine model and
the logistic mixed model. It further describes the construction of the test statistic
as well as its asymptotic distribution, for which an appropriate approximation is
6
1 Introduction
introduced. The research about the performance, suggested improvements and ex-
tensions of kernel methods for GWAS analyses that have been presented in three
different research articles. These articles have all been either published or submitted
to international peer-reviewed journals (Freytag, Bickeböller, Amos, Kneib, and
Schlather, 2012; Freytag and Bickeböller, 2013; Freytag, Manitz, Schlather, Kneib,
Amos, Risch, Chang-Claude, Heinrich, and Bickeböller, 2013), is summarized in
Chapter 3. Furthermore, this thesis also includes an original research article about
work on coverage and efficiency in current SNP chips (Ha, Freytag, and Bickeböller,
2014). The refrences and respective urls of all original articles can be found in the
Appendix A. Finally, Chapter 4 concludes this thesis by weighing the advantages and
disadvantages of gene- or network-based kernel methods in the context of genome-wide
association studies as well as looking at the future role of kernel methods in genetic
epidemiology.
7
2 Kernel Machine Test and the Gen-
eralized Linear Mixed Model
2.1 Logistic Kernel Machine Model and Its Equivalence to the
Logistic Mixed Model
The logistic kernel machine model assumes a nonparametric relationship between
the disease status and the examined genotypes adjusted for potential environmental
variables, such as age, sex or other disease relevant information. This semiparametric
model for the probability of being a case can be expressed as follows:
logit (P (yi = 1)) = xTi β + h(zi) (2.1)
Here yi indicates the disease status of the ith individual (yi = 0 unaffected, yi = 1
affected), for i = 1, . . . ,n. The vector xi is used to denote the environmental variables,
which are associated with regression coefficients summarized in vector β. Environ-
mental variables refers to any non-genomic variables, such as age or sex, that could
be informative in the context of the disease. The vector zi contains all genotypes
of the genetic variants of interest. In the case of SNPs (as assumed from here on),
genotypes are coded as usual by the number of minor alleles, i.e. zil ∈ {0,1,2} for all
SNPs l. The function h is the unspecified nonparametric function that describes the
influence of the examined genotypes on the probability of being diseased.
We assume that the unknown function h is in a reproducing kernel Hilbert space
(RKHS), HK , generated by a kernel K. In order to understand the RKHS it helps
to recall the more familiar idea of a vector space. A vector space is a mathematical
structure formed by an additive group that consists of elements, called vectors, which
can be multiplied by a real or complex number. Here, we only deal with the case
of real numbers. The inner product of a vector space, 〈x,y〉, defines a bilinear
and positive definite map of two arbitrary vectors x and y to a number. A vector
space that has an inner product and is complete, i.e. a closed set, is called Hilbert
space, H. The dimension of such a Hilbert space can be finite or infinite. A typical
example for an infinite Hilbert space is given when the elements of the space are
quadratically integrable functions. A RKHS is a Hilbert space endowed with the
inner product 〈·, ·〉HK when there exists a symmetric kernel K with the following
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properties (Schölkopf and Smola, 2002):
• K has the reproducing property, i.e 〈f,K(x,·)〉HK = f(x) for all f ∈ HK
• K(x,·) spans HK ,
where x ∈ Rd. It can be shown that K is positive semi-definite (referred to as simply
positive definite in the following), as well as unique.
Alternatively, we consider a symmetric and positive definite kernelK(x,y), x,y ∈ Rd.











holds. If the space is finite, this decomposition is nothing but the singular value
decomposition of a positive definite matrix. Because the φi’s build an orthogonal











<∞, where ‖f‖HK is the norm induced
by K and fi, ci ∈ R. Taking the inner product of two linear combinations f and g,







The kernel by defining an RKHS represents the core of any kernel method. In the
context of applications of kernel methods to GWAS, the following kernel choices are
frequently encountered: Up to now for GWAS, the linear kernel K(zi,zj) = zTi zj ,
was probably the most frequently applied kernel. Using this kernel in the logistic
kernel machine test, is equivalent to using a logistic regression with a linearly de-
fined random effect for all SNPs. In order to verify this, the reader is referred to
the relationship with the logistic mixed model discussed later (compare equation
(2.6)). Because of its linear property, this kernel fails in case of interaction between
SNPs. Another kernel successfully applied in the context of GWAS is the identity-by-
state (IBS) kernel that is constructed by evaluating the proportion of the number





2p , where I denotes an indicator function taking
the values 0 or 1 and p is the number of SNPs under consideration. This kernel has
been shown to be more robust in case of non-linearity of genotype effects than the
linear kernel (Wu, Kraft, Epstein, Taylor, Chanock, Hunter, and Lin, 2010), as it
is related to piece-wise linear regression. Like the IBS measure, other genetic simi-
larity measures have been used to construct kernels (Schaid, 2010a; Schaid, 2010b).
In fact, Schaid (2010a) interpreted the kernel evaluated at K(zi,zj) as converting
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information on genotypes of individual i and j to a quantitative value reflecting their
similarity.
The flexibility provided by the RKHS can be exploited to fit nonparametric models,
like the semiparametric model (2.1). The penalization term used to fit such models
typically has the form 〈f,f〉HK . Thus, its behavior is determined by the choice of the
kernel K that defines the RKHS. Since h ∈ HK , Liu, Ghosh, and Lin (2008) obtained





yi(xTi β + h(zi))− log{1 + exp(xTi β + h(zi))}
)
− 12λ〈h, h〉HK (2.2)
where the parameter λ controls the magnitude of the penalization. Like other penal-
ization approaches, which operate by minimizing a combination of a loss function
and a penalty, the solution is restricted in order to provide more robust and accurate
estimators. Here, the solution is constrained by the additional biological information
in form of the observed genotypes. Penalization is particularly advantageous in
situations where variables are highly correlated or when the number of variables
exceeds the sample size as in our context. In both cases the non-penalized models
would be unidentifiable, but solutions for alternative penalized models can be found.
The representer theorem of Kimeldorf and Wahba (1971) proves that a general
solution for h(zi), where zi for i = 1, . . . ,n, in the penalized maximization equation




αjK(zi,zj) = αkTi , (2.3)
where αj ∈ R for j = 1, . . . ,n are unknown and zj represent the genotype observations
of the jth individual. The vector ki is a collection of elements K(zi,z1), . . . ,K(zi,zn)
and the vector α denotes the n unknown parameters α1, . . . ,αn. Intuitively, the
nonparametric function can be interpreted as the linear closure of the similarity of zi
with the genotype realizations of all other individuals.









where K is an n × n matrix whose element (i,j) is K(zi,zj). Setting σ2K = 1λ and









It can be verified that this is the exact penalized-quasi-likelihood obtained from the
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logistic mixed model of the class of generalized linear mixed models (Liu, Ghosh, and
Lin, 2008):
logit (P (yi = 1)) = xTi β + bi
b ∼ N (0,σ2KK),
(2.6)
where b is a random effect, which is normally distributed with mean 0 and covariance
σ2KK.
The logistic mixed model (2.6) has an intuitive Bayesian interpretation due to its
hierarchical expression. The distribution associated with the random effect b can be
viewed as a prior. In particular, the kernel represents a prior correlation structure
for the dependencies among the genetic variants. Furthermore, this viewpoint also
emphasizes the dimension reduction: The kernel matrix has dimension n × n but
encompasses all genetic variants.
2.2 Score Statistics and Their Asymptotic Distribution
In order to test whether a genetic effect influences the risk of developing the in-
vestigated disease, one can consider the null hypothesis H0 : h(·) = 0 against the
alternative H1 : h(·) 6= 0. Via the connection to the logistic mixed model, we know
that this is equivalent to testing the variance component σ2K as H0 : σ2K = 0 against
the alternative H1 : σ2K > 0. Note that the null hypothesis places σ2K on the boundary
of the parameter space. To test whether all variance components are indeed zero, Lin
(1997) proposed to use a score test. Furthermore, Lin developed a unifying theory for
testing in the GLMM framework. The score test statistic, unlike the likelihood ratio,
has the advantage that estimates under the alternative hypothesis are not required.
One can simply estimate the regression coefficients β related to the environmental
variables under the null hypothesis. This makes the test extremely fast to calculate —
an invaluable property for GWAS data analysis where hundreds or thousands of such
tests need to be conducted. However, it should be noted that software limitations
can increase computation time for large samples.
In the case of the logistic mixed model with the canonical link, as considered here
(compare model (2.6)), the score test statistic is
Q = 12(y− µ̂
(0))TK(y− µ̂(0)), (2.7)
where µ̂(0) is a vector with elements µ̂(0)i = logit−1(xTi β̂), the maximum likelihood
estimate under the null hypothesis. For a detailed derivation of the score statistic
(2.7) for the logistic mixed model refer to le Cessie and van Houwelingen (1995).
Using the linear kernel K = ZTZ, where Z is the collection of the genotype vectors
for all individuals, the score statistic can be shown to be equivalent to the sum of
squares marginal scores statistics for multiple markers proposed by Pan (Pan, 2009;
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Pan, Han, and Shen, 2010). The sum of squares marginal scores statistics as well
as a weighted version have been shown to be very powerful and efficient for testing
association of multiple markers with a disease (Basu and Pan, 2011).
The score statistic Q is a quadratic form because (y− µ̂(0)) is a vector of random
variables and K is, by definition, symmetric. Since, E(y− µ̂(0)) = 0 and Cov(y−







where ζi are the eigenvalues of KV and Ui for i = 1, . . . ,l are random variables. By the
central limit theorem all Ui are approximately normally distributed. It is well known
that the distribution ofQ is therefore a weighted sum of l independent χ21 distributions.
For GLMM mixing probabilities are difficult to obtain, instead a Satterthwaite
approximation can be used (Schaid, 2010a). This procedure compares Q to a scaled
chi-square distribution with scale parameter κ and effective degrees of freedom ν.
The values of κ and ν are calculated by moment matching, i.e. the mean and variance
of Q are equated to the mean and variance of the scaled χ2ν distribution. The mean
and the variance of a quadratic form have the following expressions (Ravishanker
and Dey, 2002)
E(Q) = 12trace(PK) (2.8)








i )(1 + 6(µ̂
(0)
i )2 − 6µ̂
(0)
i ),
where P = W −WX(XTWX)−1XTW. The diagonal matrix W is defined as
diag(µ̂0(1 − µ̂(0))) and A is given by WPKPW. The mean and variance of a χ2ν
distribution scaled with κ are known to be κν and 2κ2ν, respectively. Combining
this as well as Equation (2.8) and Equation (2.9) one can easily find expressions for
the scale parameter κ and the degrees of freedom ν:




More exact methods for the approximation of the distribution that take into account
the unique setting at the boundary of the parameter space have been suggested.
One example is an approximation method by Davies (1980), which is based on the
inversion of the characteristic functions.
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3.1 Comparison of Three Summary Statistics for Ranking Genes in
Genome-Wide Association Studies
Conventional analysis of GWAS data, like single marker analysis, often yields few
SNPs that reach genome-wide significance. Therefore, researchers supplement their
results by ranking genes according to their association with the development and
progression of the investigated disease. This is typically measured by the combined
association of all SNPs in the gene with the disease. The advantages of such an
approach over single marker analysis are the disposal of the conventional significance
threshold, the potential to identify genes with many moderately associated SNPs
as well as the availability of biological context to aid interpretation. Even though
ranking genes is common practice and methods such as gene-set enrichment analysis
rely on it, there have been no comparative studies that investigate the performance
of different multiple-marker methods in the context of ranking. Thus, with the help
of simulations we set out to investigate the following questions:
• Which multi-marker method most accurately ranks genes according to their
relative strength of association? Here we investigated three different multi-
marker methods; a powerful sum test called the weighted sum of marginal
score statistics, a collapsing strategy named RareCover and the well-known
prediction method elastic net regularization. The methods were selected to be
representative of the most common classes of multiple-marker approaches.
• Do LD structures between causal SNPs, the direction of the genetic effect and
interactions between causal SNPs influence the ability to accurately rank the
genes?
• Are any of the methods able to consistently detect association with low frequency
variants? Such ability would suggest an applicability of the method to modern
sequencing data.
We simulated 9 different scenarios, all investigating different genetic aspects. In
the basic scenarios we simulated one causal gene which contained causal SNPs either
in strong LD or not in LD at all. We also simulated more advanced scenarios where
the causal gene contained an interaction between two causal SNPs, causal SNPs with
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opposing effects and causal SNPs with low minor allele frequencies. Additionally,
we simulated scenarios with two causal genes to investigate whether the different
multiple-marker methods correctly rank the causal genes according to their strength
of association with the disease. All simulations were conducted with the program
HAPGEN2 (Su, Marchini, and Donnelly, 2011) and the CEU reference sample of the
International HapMap Project (The International HapMap Consortium, 2007), which
mimics real genetic data. In order to guarantee the computational feasibility of the
simulations, we limited our investigations to genes located in a region on the first
chromosome. Instead of using known genes, we split all observed genes in this region
into "sub-genes" of equal size in terms of number of SNPs. This strategy allowed us
to avoid the use of costly permutations when calculating the association of a gene.
Overall, the weighted sum of squared score test was demonstrated to be the most
robust multi-marker methods of all investigated approaches. In particular, it was
the only method to rank the causal gene consistently at the top when interactions
between the causal SNPs were present. However, this approach struggled when causal
genes included low frequency SNPs with small effects. Under such circumstances,
the RareCover algorithm performed significantly better. Despite identifying such
associated genes reliably, the RareCover algorithm sometimes failed to rank the causal
genes in the correct order. The elastic net regularization proved computationally
extremely demanding and its performance was unimpressive in all but the simplest
scenarios. Furthermore, we showed that LD had a strong positive effect on the
performance of all methods. Note that none of the approaches was able to accurately
rank genes when the causal gene contained SNPs with opposing effects.
The results from the simulation study as well as details on the different multiple-
marker methods can be found in Freytag and Bickeböller (2013).
3.2 A Novel Kernel for Correcting Size Bias in the Logistic Kernel
Machine Test with an Application to Rheumatoid Arthritis
In their review paper on the analysis of biological pathways in GWAS, Wang, Li,
and Hakonarson (2010) named the lack of adjustment for pathway size, the failure to
incorporate LD structure and the inadequate accommodation of pathway architecture
among other challenges facing pathway-based analysis methods. Many pathway-based
methods are known to produce deflated p-values when the size of a pathway in terms
of number of genes as well as number of SNPs is not properly accounted for. Pathways
with more SNPs or genes are more likely to generate small p-values solely by random
chance. Similarly, the failure to incorporate LD structures can lead to false-positives,
as SNPs are wrongly assumed to be independent. Finally, inadequate accommodation
of pathway architecture might have a severe impact on the sensitivity and power
of an analysis approach. Since the logistic kernel machine test using the linear or
identity-by-state kernel in combination with the Saitterthwaite approximation as




• How does the size of a pathway as measured by the number of SNPs or genes
influence the type I error of the logistic kernel machine test with a linear kernel?
• Can one construct a kernel that is invariant to differential pathway sizes? Can
this kernel simultaneously account for basic architecture of a pathway, i.e.
membership of SNPs in genes, LD patterns between SNPs and interaction
between genes?
• How well does it perform compared to other approaches, such as the hierarchical
Bayes prioritization (Lewinger, Conti, Baurley, Triche, and Thomas, 2007) and
gene-set enrichment analysis (Wang, Li, and Bucan, 2007)?
At first, we investigated the questions using a combination of simulation study,
permutation study and application to a real data set on rheumatoid arthritis, which
was collected by the North American Rheumatoid Arthritis Consortium (Amos, Chen,
Seldin, Remmers, Taylor, Criswell, Lee, Plenge, Kastner, and Gregersen, 2009). Indeed
all three approaches confirmed that p-values are deflated for pathways including more
than 1,000 SNPs. In particular, for small type I error rates the method was not able
to maintain the correct type I error level. Thus, we constructed a novel kernel that
included an adjustment for the number of genes contained in the pathway as well as
for the LD-corrected number of SNPs in each gene located in the pathway. Moreover,
due to its multiplicative nature on the gene level our kernel integrates the basic
architecture of a pathway. It models interaction between all genes and groups SNPs
according to their membership in genes. We were able to verify the size-invariance
property of this kernel by the aforementioned permutation study. This was supported
by the results from the application to the GWAS on rheumatoid arthritis.
For the rheumatoid arthritis data, the logistic kernel machine test with our kernel
identified several biologically reasonable pathways as associated using a Bonferroni-
corrected significance threshold. Of these pathways the majority had previously
been mentioned to be significantly associated in at least one scientific publication
concerning GWAS and rheumatoid arthritis. Interestingly, we were able to establish
two unknown associations with pathways for APT-binding cassette transporters and
extracellular matrix receptor interaction, which are both promising and biologically
plausible. In contrast, the logistic kernel machine test employing the linear kernel
detected an improbably large number of significant pathways. Comparisons to the
two other pathway-based approaches, hierarchical Bayes prioritization and gene
set enrichment analysis, for which we used results from the analysis of the real
rheumatoid arthritis GWAS obtained by Sohns, Rosenberger, and Bickeböller (2009),
demonstrated that the logistic kernel machine test with our novel kernel was more
robust.
The results from the simulation study, permutation study and the real GWAS
data, as well as details on the construction of the novel size-invariant kernel and
similar but inferior kernels have been published in Freytag, Bickeböller, Amos, Kneib,
and Schlather (2012). Furthermore, the R-package "PathLKMT" implementing the
15
3 Summaries
logistic kernel machine test with several kernels for the analysis of GWAS data is
available upon request.
3.3 A Network-Based Kernel Machine Test for the Identification of
Risk Pathways in Genome-Wide Association Studies
A major shortcoming of the size-invariant kernel is its inability to capture the
complex nature of biological pathways. Even though the size-invariant kernel allows
the integration of basic pathway structure, it fails to exploit information on precisely
which genes interact and whether an interaction is inhibiting or activating. However,
several studies have demonstrated that knowledge about regulatory relationships
among genes can indeed be helpful for discovering associations with diseases (Chen,
Cho, and Zhao, 2011; Lee, Li, Li, Rebman, Achour, Regan, Gamazon, Chen, Yang,
Cox, and Lussier, 2013; Lim, Hao, Shaw, Patel, Szabó, Rual, Fisk, Li, Smolyar, Hill,
Barabási, Vidal, and Zoghbi, 2006; Lin, Gan, Zhang, Jones, Sjoblom, Wood, Parsons,
Papadopoulos, Kinzler, Vogelstein, Parmigiani, and Velculescu, 2007). In particular,
SNP-trait associations are often enriched in genes neighboring disease-associated
genes and genes occupying structurally relevant positions in the network. Hence, our
investigations were guided by the following questions:
• Can one achieve the integration of network topology via an appropriately
selected kernel that also adequately corrects for different gene sizes?
• Does the logistic kernel machine test with such a kernel maintain type I error? In
which genetic situations is there a power gain from using such a network-based
kernel compared to the linear kernel?
• How does the performance of the logistic kernel machine test change?
We were indeed able to construct a network-based kernel that integrates the
mathematical graph representation in form of the adjacency matrix of the network
under consideration. For this, we were required to find a method that alters any
given non-positive definite adjacency matrix to a positive definite adjacency matrix
that reflects the exact same network topology. Furthermore, the kernel includes
appropriate correction terms standardizing each gene with respect to its size as
measured by the number of SNPs. Using a null simulation we were able to show
that the logistic kernel machine test with our novel kernel maintains type I error
levels. A simple power simulation study, which was based on non-interacting causal
SNPs in different genes, demonstrated that there is a power increase when using the
network-based kernel compared to the linear kernel in certain scenarios. In these
scenarios the causal genes were neighbors or located close to each other with regards
to network topology. Applications to two real GWAS, of which one was the previously
discussed GWAS on rheumatoid arthritis and the other a GWAS on lung cancer
(German Lung Cancer Study) (Sauter, Rosenberger, Beckmann, Kropp, Mittelstrass,
Timofeeva, Wolke, Steinwachs, Scheiner, Meese, Sybrecht, Kronenberg, Dienemann,
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The LUCY-Consortium, Chang-Claude, Illig, Wichmann, Bickeböller, and Risch,
2008), also indicated clear benefits from using the network-based kernel compared to
other popular pathway based approaches.
The analysis of the rheumatoid arthritis GWAS with the logistic kernel machine
test and the network-based kernel revealed several associated pathways (Bonferroni-
corrected significance level). To our knowledge, an associated pathway for drug
metabolism, was identified for the first time as susceptibility pathway for rheumatoid
arthritis. For the lung cancer GWAS, we could not establish any pathways to be
significantly associated at Bonferroni-corrected significance level. However, this was
also the case when using the logistic kernel machine test with the linear kernel.
Interestingly, the pathway with the smallest p-values was related to the Warburg
effect known to be a characteristic of cancer-causing mutations. Additionally, using
the real data we also investigated whether network topology alone and not genotypes
were driving association results. Fortunately, we did not observe any abnormal
correlation between p-values and common descriptive statistics for networks.
For an explanation of the construction of the network-based kernel and the find-
ings from applications to the GWAS on lung cancer and rheumatoid arthritis refer
to Freytag, Manitz, Schlather, Kneib, Amos, Risch, Chang-Claude, Heinrich, and
Bickeböller (2013).
3.4 Coverage and Efficiency in Current SNP Chips
Genetic epidemiologists typically rely on commercial whole-genome SNP chips to
genotype individuals participating in a GWAS. Nowadays, multiple different SNP
chips produced by different companies are on offer. They differ greatly in the number
of SNPs covered and of course the price. Moreover, strategies of selecting SNPs to
be part of a SNP chip vary from chip to chip and are markedly different between
companies. This can result in one chip covering more of the genome than another
chip of equal size, because LD allows investigators to infer the genotype of SNPs not
on the chip with the help of an appropriate reference set. Furthermore, as different
populations exhibit different LD patterns, the performance of a chip need not be
equal across different ethnicities. Since the success of a GWAS in part depends on
cost-effective and thorough coverage of the whole genome, we tried to answer the
following questions in our analysis of coverage and efficiency of the more recent SNP
chips of Affymetrix and Illumina:
• Which chip covers the greatest number of variation in the European, Asian or
African human genome?
• Which chip is the most efficient with regards to exploiting LD structures,
to covering SNPs which are not in LD with other SNPs and to cost-benefit
analysis?
• In particular, we were interested in the performance of Affymetrix’ population-
optimized chips, which cover SNPs selected based on the LD patterns observed
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in the population of interest. So, are population-optimized chips truly able to
provide better coverage of the genome for their targeted ethnicity than chips of
comparable size or chips of equal price?
In order to answer these questions, we calculated gene coverage as well as local
coverage using the definition of coverage rate by Li, Li, and Guan (2008). Since
this coverage rate does not account for chip size, we developed efficiency measures
standardized with regards to chip size. Efficiency was measured on the one hand by
how well LD is exploited and on the other hand by how many SNPs not in LD with
any other SNPs are covered. Comparison of different chips that also take different
chip prices into account were provided through our newly introduced cost-benefit
ratio. For all calculation, we used samples of appropriate populations found in the
1000 Genome Project Version 3 (The 1000 Genomes Project Consortium, 2012) as a
reference set.
None of the investigated Illumina or Affymetrix SNP chips reached the advertised
coverage rate stated on the website of the respective company. In general, the local
as well as gene coverage of SNPs with minor allele frequency greater than or equal to
5% achieved by chips including more than two million SNPs was excellent. However,
coverage of SNPs with minor allele frequency down to 1% was considerably lower
even for such extremely big chips. In particular, the performance of the chips for
the African population was poor, as this population exhibits lower levels of LD.
Interestingly, while the population-targeted chips counted towards the chips with
the lowest local and gene coverage in their particular size range, they were able to
outperform all other chips in terms of efficiency and cost-benefit (Asian and African
population).
The definitions of the newly introduced measures and the results on coverage,




Kernel methods, like the logistic kernel machine test, possess many characteristics
that recommend them for the analysis of association between a disease and biologically
meaningful sets of multiple SNPs. Mathematically, such methods are founded in the
rigorous framework of the reproducing kernel Hilbert space. In this framework, a
model can be fitted with the help of a loss function and a penalty function that is
defined by the choice of a kernel. Such an approach proves extremely flexible as well
as powerful. The kernel, which aims to capture the genetic similarity between any two
individuals in the study, can be chosen from the enormous range of symmetric and
positive definite functions. Thus, kernel methods enjoy expressive power to reflect
assumptions about genetic relationships. Furthermore, prior biological knowledge,
such as gene-gene interaction networks, can be incorporated in the kernel without
the need to change the statistical procedure of the model fitting. Also, such incorpo-
ration of prior biological knowledge offers biological context for the interpretation
of association results and might therefore lead to treatment options. Finally, kernel
methods are often faster than comparable multi-marker approaches, because they
involve a considerable reduction in the dimensionality of the problem. Instead of
the number of markers in the model, the speed of the analysis is determined by the
number of individuals in the study.
Kernel methods are not without disadvantages. Even though, calculations required
to fit kernel models are generally fast for GWAS of moderate size, this changes
dramatically when GWAS include 10,000 individuals or more. Studies of this size are
frequently encountered in meta-analysis, where several studies are pooled in order to
gain more statistical power. However, at least for the logistic kernel machine test
a solution to this problem might be the use of modern graphics processing units,
which can be modified to handle large matrix calculations (Fatahalian, Sugerman,
and Hanrahan, 2004). Despite offering tremendous flexibility, the generality of the
kernel constitutes another disadvantage. This generality can make it difficult to know
how to construct a good kernel for a specific problem (Schaid, 2010a). Furthermore,
it can sometimes be challenging to translate a model to a symmetric and positive
definite function reflecting genetic similarity. For example, including the direction of
gene-gene interactions in a network-based kernel for the detection of pathway-disease
association violates the requirement of symmetry. A further disadvantage of the
logistic kernel machine test is that we can only obtain information about association
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between the disease and gene or pathway. Even if we discover an association, we do
not have information which genes or which SNPs in the pathway or gene are precisely
involved in the pathogenesis of a particular disease. Additionally, this limitation to
a single level prevents a broader systems biological perspective. Genes do not act
independently in the human organism. The same is true for pathways. Therefore, it
would be of great interest to be able to model the associations of genes or pathways
imbedded in the broader context of the human organism. This should also enable
proper consideration of SNPs or genes which are shared among many pathways or
genes, respectively.
More challenging than the statistical problems associated with kernel methods are
problems of biological nature associated with all pathway-based methods. Modern
genotyping chips do not exclusively include SNPs in genes or regulatory sequences.
Even though there exist several strategies for assignment of SNPs outside of such
regions, assignment rules are likely to be considered arbitrary (Cantor, Lange, and
Sinsheimer, 2010). In general, SNPs located more than 500kbp from the nearest known
gene often need to be excluded from the analysis. Hence, important associations
outside coding regions might be missed. Moreover, the lack of formal assignment may
limit the reproducibility of results obtained by pathway-based methods. However, in
the future with the help of sequencing studies it can be hoped that the functionality
of more and more SNPs will have been predicted (Petersen, Alvarez, DeClaire, and
Tintle, 2013). The other major challenges facing pathway-based approaches, and
even more so network-based approaches, are inaccuracy and incompleteness of the
available regulatory network models. However, in the coming years, it is expected that
models will become better, dramatically increasing their ability to yield important
insights into the development and progression of diseases (Califano, Butte, Friend,
Ideker, and Schadt, 2012). Furthermore, a great abundance of ever evolving pathway
databases addressed to different research audiences also hinders the reproduction
of results (Cantor, Lange, and Sinsheimer, 2010). Not only are pathway databases
inconsistent, but the choice of a database severely biases analyses (Elbers, van Eijk,
Franke, Mulder, van der Schouw, Wijmenga, and Onland-Moret, 2009). A solution to
this particular problem might lie "[...in the] combined use of manually curated path-
ways and electronically compiled pathways to ensure comprehensive coverage as well
as high-quality information for well-studied pathways" (Wang, Li, and Hakonarson,
2010).
Because of their immense flexibility, kernel methods are one promising approach in
order to overcome the challenges posed by modern GWAS data. They are ideally
suited to reflect the complex understanding of the human organism that researchers
are in the process of elucidating. The ability of kernel methods to adjust to novel
biological concepts is demonstrated by our research into modifications of the kernel
aiming at a systems biological perspective. In particular, we show that it is possible
to incorporate a model of complex interactions — a network — into analyses, which
points to the possibility of combining other types of microbiological data with the
help of kernel methods. Moreover, the flexibility provided by the kernel can be
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exploited in order to solve problems of statistical nature. For example, we conducted
simulation studies showing that for some kernels a bias owing to the different sizes
of the pathways or genes can be incurred. An appropriately chosen kernel, like our
size-invariant kernel, can help to prevent such biases.
There already exist several empirical as well as simulation studies concerned with
the performance of kernel methods compared to other approaches in the context of
GWAS data. As part of our work, we compared the performance of the logistic kernel
machine test and the closely related sum of squared score test to other approaches
frequently applied to GWAS. Even though for the majority of simulation scenarios
and for all real data examples the performance of kernel methods was superior, further
studies are needed for validation. This is especially the case for kernel methods used
for pathway-based analysis, as our understanding of pathways quickly evolves. In
the near future, as more knowledge about the regulatory processes in gene-gene
networks becomes available, kernel methods applied to pathway-based analysis of
GWAS data should begin to catch the dynamic and cell-specific nature of pathways.
Ideally, approaches should incorporate dynamic networks specifically adapted towards
the investigated disease rather than integrating static networks. While this will
certainly require cooperation between many different disciplines, statisticians will
need to reevaluate the appropriateness of the currently used methods. Because of
their flexibility, it is likely that modification of kernel methods in order to deal with
dynamic biological process regulation is possible.
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